Prostatis Group’s iShares International Select Dividend ETF IDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,286
Closed -$226K 162
2025
Q1
$226K Sell
7,286
-506
-6% -$14.8K 0.07% 140
2024
Q4
$213K Sell
7,792
-831
-10% -$23.8K 0.06% 148
2024
Q3
$261K Buy
8,623
+35
+0.4% +$1.02K 0.09% 117
2024
Q2
$238K Sell
8,588
-230
-3% -$6.54K 0.08% 132
2024
Q1
$247K Sell
8,818
-70,903
-89% -$1.96M 0.09% 123
2023
Q4
$2.23M Buy
79,721
+11,802
+17% +$308K 0.93% 33
2023
Q3
$1.78M Sell
67,919
-1,390,228
-95% -$36.8M 0.87% 26
2023
Q2
$1.53M Buy
+1,458,147
New +$39.8M 0.71% 35

Other funds holding IDV

Prostatis Group's IDV Position: Q2 2025 in Review

Prostatis Group sold out of iShares International Select Dividend ETF (IDV) in Q2 2025, closing a stake of 7,286 shares — an estimated $226K sold.

Prostatis Group first reported a position in IDV in Q2 2023 and held it in 8 quarters. The position peaked at $2.23M in Q4 2023. 509 funds tracked by Wall St. Rank hold IDV as of Q2 2025.

  • Prostatis Group reported no remaining iShares International Select Dividend ETF position as of Q2 2025 after selling out during the quarter.
  • Prostatis Group sold 7,286 iShares International Select Dividend ETF shares in Q2 2025, an estimated $226K.
  • Prostatis Group first reported a position in iShares International Select Dividend ETF in Q2 2023 and held it in 8 quarters.
  • Prostatis Group's iShares International Select Dividend ETF position peaked at $2.23M in Q4 2023.
  • 509 funds tracked by Wall St. Rank held iShares International Select Dividend ETF as of Q2 2025.

Based on Prostatis Group's 13F filing for Q2 2025, filed 25 Jul 2025.